---
figid: PMC7862249__41418_2020_706_Fig1_HTML
figlink: pmc/articles/PMC7862249/figure/Fig1/
number: Fig. 1
caption: A Schematic of the ubiquitination cascade and opposing deubiquitination.
  During ubiquitination, ubiquitin is first attached to an E1 ubiquitin activating
  enzyme in an ATP-dependent manner before being transferred to an E2 ubiquitin conjugating
  enzyme. The Ub~E2 conjugate is then recognised by an E3 ubiquitin ligase, and ubiquitin
  is then transferred either directly to a substrate (for RING family E3 ubiquitin
  ligases) or first attached to the E3 ubiquitin ligase before being transferred to
  the substrate (for HECT and RBR family E3 ubiquitin ligases). The reverse reaction,
  deubiquitination, is catalysed by the deubiquitinating enzymes (DUBs) which remove
  ubiquitin from ubiquitinated substrates. B Ubiquitin–proteasome system. Ubiquitination
  of substrates can target proteins directly, or via ubiquitin-binding shuttle proteins
  such as UBQLN2, to the proteasome for proteolysis. Deubiquitination at the proteasome
  by proteasome-associated DUBs (USP14, UCH37) can rescue substrates from degradation.
  C Autophagy–lysosomal pathway. Specific E3 ligases ubiquitinate protein aggregates
  (e.g. CHIP, NEDD4, TRAF6), or damaged organelles (e.g. Parkin), to recruit autophagy
  receptors (e.g. p62, Neighbour of BRCA1 gene 1 (NBR1), OPTN, NDP52, TAX1BP1) that
  can simultaneously bind ubiquitin and Atg8-like proteins (LC3s). The Atg proteins
  catalyse the conjugation of the lipid phosphatidylethanolamine (PE) to LC3s and
  mediate the expansion of the autophagophore. D Non-degradative ubiquitin signalling.
  Ubiquitination can influence multiple pathways through degradative mechanisms or
  through non-degradative mechanisms. Non-proteolytic roles of ubiquitin often involve
  atypical chain linkage types.
pmcid: PMC7862249
papertitle: 'Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic
  opportunities.'
reftext: Marlene F. Schmidt, et al. Cell Death Differ. 2021 Feb;28(2):570-590.
pmc_ranked_result_index: '44955'
pathway_score: 0.8710644
filename: 41418_2020_706_Fig1_HTML.jpg
figtitle: 'Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities'
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7862249__41418_2020_706_Fig1_HTML.html
  '@type': Dataset
  description: A Schematic of the ubiquitination cascade and opposing deubiquitination.
    During ubiquitination, ubiquitin is first attached to an E1 ubiquitin activating
    enzyme in an ATP-dependent manner before being transferred to an E2 ubiquitin
    conjugating enzyme. The Ub~E2 conjugate is then recognised by an E3 ubiquitin
    ligase, and ubiquitin is then transferred either directly to a substrate (for
    RING family E3 ubiquitin ligases) or first attached to the E3 ubiquitin ligase
    before being transferred to the substrate (for HECT and RBR family E3 ubiquitin
    ligases). The reverse reaction, deubiquitination, is catalysed by the deubiquitinating
    enzymes (DUBs) which remove ubiquitin from ubiquitinated substrates. B Ubiquitin–proteasome
    system. Ubiquitination of substrates can target proteins directly, or via ubiquitin-binding
    shuttle proteins such as UBQLN2, to the proteasome for proteolysis. Deubiquitination
    at the proteasome by proteasome-associated DUBs (USP14, UCH37) can rescue substrates
    from degradation. C Autophagy–lysosomal pathway. Specific E3 ligases ubiquitinate
    protein aggregates (e.g. CHIP, NEDD4, TRAF6), or damaged organelles (e.g. Parkin),
    to recruit autophagy receptors (e.g. p62, Neighbour of BRCA1 gene 1 (NBR1), OPTN,
    NDP52, TAX1BP1) that can simultaneously bind ubiquitin and Atg8-like proteins
    (LC3s). The Atg proteins catalyse the conjugation of the lipid phosphatidylethanolamine
    (PE) to LC3s and mediate the expansion of the autophagophore. D Non-degradative
    ubiquitin signalling. Ubiquitination can influence multiple pathways through degradative
    mechanisms or through non-degradative mechanisms. Non-proteolytic roles of ubiquitin
    often involve atypical chain linkage types.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PPL
  - MFAP1
  - HMBS
  - USP14
  - UCHL5
  - PSMD14
  - ATG7
  - ATG12
  - TRAF6
  - STUB1
  - NEDD4
  - ATG5
  - ATG10
  - MAP1LC3A
  - NBR1
  - TAX1BP1
  - OPTN
  - CALCOCO2
  - ATG3
  - ATP AMP
  - PPI
  - Lys
  - Cys
  - AMP
  - UPS
genes:
- word: PPI
  symbol: PPL
  source: hgnc_symbol
  hgnc_symbol: PPL
  entrez: '5493'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: (UPS)
  symbol: UPS
  source: hgnc_prev_symbol
  hgnc_symbol: HMBS
  entrez: '3145'
- word: USP14
  symbol: USP14
  source: hgnc_symbol
  hgnc_symbol: USP14
  entrez: '9097'
- word: UCH37
  symbol: UCH37
  source: hgnc_alias_symbol
  hgnc_symbol: UCHL5
  entrez: '51377'
- word: Rpn11,
  symbol: Rpn11
  source: hgnc_alias_symbol
  hgnc_symbol: PSMD14
  entrez: '10213'
- word: Atg7
  symbol: ATG7
  source: hgnc_symbol
  hgnc_symbol: ATG7
  entrez: '10533'
- word: Atg12
  symbol: ATG12
  source: hgnc_symbol
  hgnc_symbol: ATG12
  entrez: '9140'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: CHIP,
  symbol: CHIP
  source: hgnc_alias_symbol
  hgnc_symbol: STUB1
  entrez: '10273'
- word: NEDD4
  symbol: NEDD4
  source: hgnc_symbol
  hgnc_symbol: NEDD4
  entrez: '4734'
- word: Atg12
  symbol: ATG12
  source: hgnc_symbol
  hgnc_symbol: ATG12
  entrez: '9140'
- word: Atg5
  symbol: ATG5
  source: hgnc_symbol
  hgnc_symbol: ATG5
  entrez: '9474'
- word: Atg12
  symbol: ATG12
  source: hgnc_symbol
  hgnc_symbol: ATG12
  entrez: '9140'
- word: Atg10
  symbol: ATG10
  source: hgnc_symbol
  hgnc_symbol: ATG10
  entrez: '83734'
- word: Atg5
  symbol: ATG5
  source: hgnc_symbol
  hgnc_symbol: ATG5
  entrez: '9474'
- word: LC3
  symbol: LC3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP1LC3A
  entrez: '84557'
- word: NBR1
  symbol: NBR1
  source: hgnc_symbol
  hgnc_symbol: NBR1
  entrez: '4077'
- word: TAX1BP1
  symbol: TAX1BP1
  source: hgnc_symbol
  hgnc_symbol: TAX1BP1
  entrez: '8887'
- word: OPTN
  symbol: OPTN
  source: hgnc_symbol
  hgnc_symbol: OPTN
  entrez: '10133'
- word: NDP52
  symbol: NDP52
  source: hgnc_alias_symbol
  hgnc_symbol: CALCOCO2
  entrez: '10241'
- word: Atg3
  symbol: ATG3
  source: hgnc_symbol
  hgnc_symbol: ATG3
  entrez: '64422'
- word: LC3
  symbol: LC3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP1LC3A
  entrez: '84557'
- word: LC3
  symbol: LC3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP1LC3A
  entrez: '84557'
- word: Atg7
  symbol: ATG7
  source: hgnc_symbol
  hgnc_symbol: ATG7
  entrez: '10533'
- word: LC3
  symbol: LC3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP1LC3A
  entrez: '84557'
- word: LC3
  symbol: LC3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP1LC3A
  entrez: '84557'
- word: LC3
  symbol: LC3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP1LC3A
  entrez: '84557'
- word: AMP+
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: PPI
  symbol: PPL
  source: hgnc_symbol
  hgnc_symbol: PPL
  entrez: '5493'
chemicals:
- word: ATP AMP
  source: MESH
  identifier: D000255
- word: PPI
  source: MESH
  identifier: C119604
- word: Lys
  source: MESH
  identifier: C026591
- word: Cys
  source: MESH
  identifier: C046557
- word: AMP
  source: MESH
  identifier: D000249
diseases:
- word: UPS
  source: MESH
  identifier: D017118
---
